Cargando…

Overall and disease‐specific survival of Hodgkin lymphoma survivors who subsequently developed gastrointestinal cancer

BACKGROUND: Hodgkin lymphoma (HL) survivors have an increased risk of gastrointestinal (GI) cancer. This study aims to evaluate whether survival of patients who survived HL and developed GI cancer differs from survival of first primary GI cancer patients. METHODS: Overall and cause‐specific survival...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rigter, Lisanne S., Schaapveld, Michael, Janus, Cecile P. M., Krol, Augustinus D. G., van der Maazen, Richard W. M., Roesink, Judith, Zijlstra, Josee M., van Imhoff, Gustaaf W., Poortmans, Philip M. P., Beijert, Max, Lugtenburg, Pieternella J., Visser, Otto, Snaebjornsson, Petur, van Eggermond, Anna M., Aleman, Berthe M. P., van Leeuwen, Flora E., van Leerdam, Monique E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346242/ https://www.ncbi.nlm.nih.gov/pubmed/30592184 http://dx.doi.org/10.1002/cam4.1922

Ejemplares similares

Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients
por: de Vries, Simone, et al.
Publicado: (2020)

Diagnostic Accuracy of Stool Tests for Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors
por: Ykema, Berbel, et al.
Publicado: (2020)

High prevalence of advanced colorectal neoplasia and serrated polyposis syndrome in Hodgkin lymphoma survivors
por: Rigter, Lisanne S., et al.
Publicado: (2018)

Clinicopathological features and risk factors for developing colorectal neoplasia in Hodgkin’s lymphoma survivors
por: Ykema, Berbel L. M., et al.
Publicado: (2021)

Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors
por: van Eggermond, Anna M, et al.
Publicado: (2017)

Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic Radiotherapy
por: Ykema, Berbel L.M., et al.
Publicado: (2022)

Molecular characterization of gastric adenocarcinoma diagnosed in patients previously treated for Hodgkin lymphoma or testicular cancer
por: Rigter, Lisanne S., et al.
Publicado: (2022)

High burden of subsequent malignant neoplasms and cardiovascular disease in long-term Hodgkin lymphoma survivors
por: de Vries, Simone, et al.
Publicado: (2018)

P073: Increased risk of colorectal cancer following treatment for Hodgkin lymphoma
por: Geurts, Yvonne M.G., et al.
Publicado: (2022)

Colorectal cancer surveillance in Hodgkin lymphoma survivors at increased risk of therapy-related colorectal cancer: study design
por: Rigter, Lisanne S., et al.
Publicado: (2017)

Association of Radiation and Procarbazine Dose With Risk of Colorectal Cancer Among Survivors of Hodgkin Lymphoma
por: Geurts, Yvonne M., et al.
Publicado: (2023)

Comparing causes of death of Hodgkin lymphoma and breast cancer patients between medical records and cause-of-death statistics
por: de Vries, Simone, et al.
Publicado: (2018)

Risk for Valvular Heart Disease After Treatment for Hodgkin Lymphoma
por: Cutter, David J., et al.
Publicado: (2015)

Gene expression profiles of esophageal squamous cell cancers in Hodgkin lymphoma survivors versus sporadic cases
por: Ykema, Berbel L. M., et al.
Publicado: (2020)

Comparison of outcomes between Hodgkin's lymphoma patients treated in and outside clinical trials: A study based on the EORTC‐Dutch late effects cohort‐linked data
por: Juul, Sidsel Jacobsen, et al.
Publicado: (2022)

P070: Design of the INSIGHT study, evaluation of long-term follow-up care for lymphoma survivors in the Netherlands: does survivorship care at the BETER clinics reduce morbidity and mortality from late effects of lymphoma treatment and associated costs?
por: Nijdam, Annelies, et al.
Publicado: (2022)

P071: First results of cardiovascular screening in a survivorship care program for Hodgkin lymphoma survivors in the Netherlands
por: Lammers, Eline M.J., et al.
Publicado: (2022)

T064: Doxorubicin exposure and breast cancer risk in adolescent and adult Hodgkin lymphoma survivors
por: Neppelenbroek, Suzanne I.M., et al.
Publicado: (2022)

P080: The BETER-REFLECT Biobank: a REsource For studies on Late Effects of Cancer Treatment
por: Mieras, Adinda, et al.
Publicado: (2022)

Response to “Cytomegalovirus Enterocolitis in a Patient with Refractory Immune-Related Colitis”
por: van Turenhout, Sietze, et al.
Publicado: (2021)

Primary therapy and survival among patients with nodular lymphocyte‐predominant Hodgkin lymphoma: a population‐based analysis in the Netherlands, 1993–2016
por: Posthuma, Hidde L. A., et al.
Publicado: (2019)

Conditional relative survival among patients with nodular lymphocyte-predominant Hodgkin lymphoma in the Netherlands
por: Posthuma, Hidde L. A., et al.
Publicado: (2021)

P1139: COMPARISON OF 6XR-CHOP21 VERSUS 6XR-CHOP+2R FOR ADVANCED-STAGE DIFFUSE LARGE B-CELL LYMPHOMA: A PROPENSITY SCORE WEIGHTED POPULATION-BASED ANALYSIS
por: Maas, Carolien, et al.
Publicado: (2023)

A case series of intestinal adenomatous polyposis of unidentified etiology; a late effect of irradiation?
por: Rigter, Lisanne Sara, et al.
Publicado: (2016)

Electrolyte disorders secondary to venetoclax
por: van der Lubbe, Nils, et al.
Publicado: (2020)

TCR V α- and V ß-Gene Segment Use in T-Cell Subcultures Derived from a Type-III Bare Lymphocyte Syndrome Patient Deficient in MHC Class-II Expression
por: Lambert, M., et al.
Publicado: (1992)

Cardiovascular Morbidity and Mortality After Treatment for Ductal Carcinoma In Situ of the Breast
por: Boekel, Naomi B., et al.
Publicado: (2014)

(18)F-FDG PET baseline radiomics features improve the prediction of treatment outcome in diffuse large B-cell lymphoma
por: Eertink, Jakoba J., et al.
Publicado: (2021)

EUS-guided fiducial marker placement for radiotherapy in rectal cancer: feasibility of two placement strategies and four fiducial types
por: Rigter, Lisanne S., et al.
Publicado: (2019)

Cost-effectiveness and resource use of implementing MRI-guided NACT in ER-positive/HER2-negative breast cancers in The Netherlands
por: Miquel-Cases, Anna, et al.
Publicado: (2016)

Rationale and design of a cohort study on primary ovarian insufficiency in female survivors of Hodgkin’s lymphoma: influence on long-term adverse effects (SOPHIA)
por: Krul, Inge M, et al.
Publicado: (2018)

Comparing lesion and feature selections to predict progression in newly diagnosed DLBCL patients with FDG PET/CT radiomics features
por: Eertink, Jakoba J., et al.
Publicado: (2022)

Reproducibility of Gene Expression Signatures in Diffuse Large B-Cell Lymphoma
por: Plaça, Jessica Rodrigues, et al.
Publicado: (2022)

Immune checkpoint inhibition-related colitis: symptoms, endoscopic features, histology and response to management
por: Geukes Foppen, Marnix H, et al.
Publicado: (2018)

Retrospective methods to estimate radiation dose at the site of breast cancer development after Hodgkin lymphoma radiotherapy
por: Russell, Nicola S., et al.
Publicado: (2017)

Patients’ decision-making, experiences and preferences regarding pixantrone treatment in relapsed or refractory diffuse large B-cell lymphoma: study protocol for a longitudinal mixed methods study
por: van Hoogdalem, Lothar E, et al.
Publicado: (2019)

Myocardial dysfunction in long‐term breast cancer survivors treated at ages 40–50 years
por: Jacobse, Judy N., et al.
Publicado: (2019)

Importziekten
por: van Thiel, P.P.A.M., et al.
Publicado: (2014)

No sex differential in relative survival among older patients with DLBCL treated with R-CHOP21: a population-based study
por: Geerdes, Emma E., et al.
Publicado: (2023)

An Integrated Process and Outcome Evaluation of a Web-Based Communication Tool for Patients With Malignant Lymphoma: Randomized Controlled Trial
por: van Bruinessen, Inge Renske, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2h66aqtr0r1inn70fj761ccp7t